Glomerular
sclerosis of diverse etiologies is characterized by mesangial matrix accumulation, with
transforming growth factor-beta (
TGFbeta) an important pathogenic factor. The
GTPase RhoA mediates
TGFbeta-induced matrix accumulation in some settings. Here we study the role of the membrane microdomain caveolae in
TGFbeta-induced RhoA activation and
fibronectin upregulation in mesangial cells (MC). In primary rat MC, TGFbeta1 time dependently increased RhoA and downstream
Rho kinase activation. Rho pathway inhibition blocked TGFbeta1-induced upregulation of
fibronectin transcript and
protein. TGFbeta1-induced RhoA activation was prevented by disrupting caveolae with
cholesterol depletion and rescued by
cholesterol repletion. Compared with wild types, RhoA/
Rho kinase activation was absent in MC lacking caveolae. Reexpression of
caveolin-1 (and caveolae) restored these responses. Phosphorylation of
caveolin-1 on Y14, effected by
Src kinases, has been implicated in signaling responses. Overexpression of nonphosphorylatable
caveolin-1 Y14A prevented TGFbeta1-induced RhoA activation. TGFbeta1 also activated Src, and its inhibition blocked RhoA activation. Furthermore, TGFbeta1 led to association of RhoA and
caveolin-1. This was prevented by Src or
TGFbeta receptor I inhibition, and by
caveolin-1 Y14A overexpression. Last,
fibronectin upregulation by TGFbeta1 was blocked by Src inhibition, not seen in
caveolin-1 knockout MC, and restored by
caveolin-1 reexpression in the latter. TGFbeta1-induced
collagen I accumulation also required caveolae. TGFbeta1-mediated Smad2/3 activation, however, did not require caveolae. We conclude that RhoA/
Rho kinase mediates
TGFbeta-induced
fibronectin upregulation. This requires caveolae and
caveolin-1 interaction with RhoA. Interference with
caveolin/caveolae or RhoA signaling thus represents a potential target for the treatment of fibrotic renal disease.